Neeraj Sharma, CEO and Managing Director, OneSource Specialty Pharma, outlines, The global market for GLP1based therapies is experiencing unprecedented growth, given the increasing incidence of Type 2 diabetes and obesity and its efficacy in the management of both diseases
HELPS IMPROVE TEXTURE & MOISTURE LEVELS
As you shed those extra pounds, the burden on your joints decreases, allowing for easier movement and reduced discomfort
The resulting suspension was separated by centrifugation at 12,000 rpm for 30 min at 4 C, and the protein concentrations was performed as in a previous report [28]
Dose escalation follows a gradual titration schedule based on individual response and tolerance, as determined by the patients physician